Studies have found that inhibited heparanase activation could protect pulmonary endothelial glycocalyx integrity and reduce endothelial dysfunction (Wang et al., 2016; Huang et al., 2018), which indicated that inhibition of HPSE1 activity or upstream regulatory mechanisms might be helpful in inhibiting the vascular disease progression. Here, HPSE is linked to endothelial dysfunction.